Toward clarifying ASAM’s inpatient and residential benzodiazepine tapering recommendations - Top-Institutions - MDSpire

Toward clarifying ASAM’s inpatient and residential benzodiazepine tapering recommendations

  • By

  • Christopher K. Blazes

  • Stephen Leung

  • Doryn Davis Chervin

  • Bernard Silvernail

  • May 26, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Yale School of Medicine / Yale New Haven Hospital
    Yale School of Medicine / Yale New Haven Hospital

    New Haven, Connecticut

    Key Differentiators

    • Addiction Medicine

  • #2

    University of Michigan (Michigan Medicine)
    University of Michigan (Michigan Medicine)

    Ann Arbor, Michigan

    Key Differentiators

    • Addiction Medicine

Original Source(s)

Toward clarifying ASAM’s inpatient and residential benzodiazepine tapering recommendations

  • by Christopher K. Blazes, Stephen Leung, Doryn Davis Chervin, Bernard Silvernail

  • May 26, 2026

Related Content

Neuroimaging and neurophysiologic biomarkers for diagnosis and prognosis of depressive disorders, bipolar disorder, anxiety disorders, obsessive compulsive disorder, posttraumatic stress disorder, and substance use disorder: an evidence map

Digital Twin Model May Improve Alcohol Intake Reconstruction

Integrated biomarker framework supports evaluation of drinking scenarios in forensic settings

5 Key Facts on Adolescent Mental Health and Substance Use Disorders